4//SEC Filing
Kunkel Lori Anne 4
Accession 0001536368-25-000004
CIK 0001796280other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:47 PM ET
Size
7.2 KB
Accession
0001536368-25-000004
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-04$3.75/sh+5,534$20,753→ 74,200 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-04−5,534→ 0 totalExercise: $3.75Exp: 2032-06-16→ Common Stock (5,534 underlying)
Footnotes (1)
- [F1](A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022.
Documents
Issuer
Oric Pharmaceuticals, Inc.
CIK 0001796280
Entity typeother
Related Parties
1- filerCIK 0001536368
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:47 PM ET
- Size
- 7.2 KB